AzTrials
AzTrials

AtelectasisNCT07758517

Fresh Gas Flow Rate and Perioperative Lung Aeration Assessed by Lung Ultrasound in Septoplasty

An observational study of Atelectasis and Nasal Septal Deviation, run by Fatih Sultan Mehmet Training and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This prospective, single-center observational cohort study evaluated the association between fresh gas flow rate during inhalational anesthesia and perioperative changes in lung aeration in adults undergoing elective surgery for nasal septal deviation. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Atelectasis, Nasal Septal Deviation
What is being tested?
Fresh Gas Flow Rate of 1 L/min and Fresh Gas Flow Rate of 3 L/min
How many people
2 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 Jan 2024to 15 Apr 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population consisted of adults aged 18 to 65 years with American Society of Anesthesiologists physical status I or II who underwent elective septoplasty for nasal septal deviation under general anesthesia at Fatih Sultan Mehmet Training and Research Hospital. Eligible consenting participants were observed prospectively, and their perioperative clinical and lung ultrasound data were recorded. Fresh gas flow rates were selected by the attending anesthesiologist as part of routine clinical care.

Who may be able to join

  • Adults aged 18 to 65 years
  • Scheduled to undergo elective septoplasty for nasal septal deviation under general anesthesia
  • American Society of Anesthesiologists physical status I or II
  • Body mass index of 35 kg/m² or less
  • Provided written informed consent to participate

Who cannot join

  • Acute respiratory tract infection within the preceding 15 days
  • Chronic pulmonary disease
  • Malignancy
  • Significant hepatic, renal, or cardiac disease
  • Limited ability to cooperate with the study assessments
  • Cerebrovascular or neuromuscular disease
Show all 10Show fewer
  • Previous thoracic surgery
  • Chest wall deformity
  • Emergency surgery
  • History of clinically relevant allergy

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Istanbul Provincial Health Directorate Fatih Sultan Mehmet Training and Research Hospital

    Istanbul, 34000

Other trials in Turkey (Türkiye)

About this study

Official title: Evaluation of the Association Between Fresh Gas Flow Rate During Inhalational Anesthesia and Perioperative Pulmonary Aeration Assessed Using the Lung Ultrasound Score in Patients Undergoing Septoplasty: A Prospective Observational Study

This prospective, single-center observational cohort study evaluated the association between fresh gas flow rate during inhalational anesthesia and perioperative changes in lung aeration in adults undergoing elective surgery for nasal septal deviation.

Participants were classified into two cohorts according to the fresh gas flow rate used during routine anesthesia care: 1 L/min or 3 L/min. The flow rate was selected independently by the attending anesthesiologist as part of routine clinical practice and was not assigned by the research protocol.

Lung aeration was assessed using the modified lung ultrasound score before anesthesia, after tracheal intubation, before extubation, 15 minutes after admission to the post-anesthesia care unit, and before discharge from the post-anesthesia care unit. Perioperative oxygenation, hemodynamic variables, respiratory mechanics, and early postoperative recovery findings were also recorded.

Read the detailed description

This was a prospective, single-center observational cohort study conducted at Fatih Sultan Mehmet Training and Research Hospital. Adult patients aged 18 to 65 years with American Society of Anesthesiologists physical status I or II who underwent elective surgery for nasal septal deviation under general anesthesia were evaluated.

All participants provided written informed consent before enrollment. Anesthetic management was performed according to routine institutional clinical practice. The fresh gas flow rate was determined independently by the attending anesthesiologist and was not assigned or modified by the research protocol. Participants were subsequently classified into two observational cohorts according to the documented fresh gas flow rate used during inhalational anesthesia: 1 L/min or 3 L/min. No randomization was performed.

Lung ultrasound examinations were performed at five perioperative time points: before induction of anesthesia, after tracheal intubation, before extubation, 15 minutes after admission to the post-anesthesia care unit, and approximately 30 minutes after admission or immediately before discharge from the post-anesthesia care unit.

Lung aeration was evaluated in 12 thoracic regions using a modified lung ultrasound score. Each region was scored from 0 to 3 according to the observed ultrasound pattern. A score of 0 represented normal aeration, while scores of 1, 2, and 3 represented mild, moderate, and severe loss of aeration, respectively. The total score ranged from 0 to 36, with higher scores indicating greater loss of lung aeration.

The primary objective was to compare perioperative changes in the lung ultrasound score between patients receiving fresh gas flow rates of 1 L/min and 3 L/min during routine anesthesia. Additional recorded variables included heart rate, systolic, diastolic, and mean arterial pressure, peripheral oxygen saturation, perfusion index, end-tidal carbon dioxide, inspired and expired oxygen concentrations, body temperature, peak airway pressure, airway resistance, and dynamic lung compliance. Early postoperative findings, including pain intensity, nausea, vomiting, and shivering, were also evaluated in the post-anesthesia care unit.

Being tested
Fresh Gas Flow Rate of 1 L/min, Fresh Gas Flow Rate of 3 L/min
Keywords
Fresh gas flow rate, Low-flow anesthesia, Inhalational anesthesia, Lung ultrasound score, Lung ultrasound, Perioperative atelectasis, Pulmonary aeration, Septoplasty, Desflurane, Post-anesthesia care unit
Medical subject headings
Pulmonary Atelectasis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fresh Gas Flow Rate of 1 L/minOther

    During routine inhalational general anesthesia, a fresh gas flow rate of 1 L/min was used. The flow rate was selected independently by the attending anesthesiologist according to routine clinical practice and was not assigned or modified by the research protocol. This exposure was evaluated in relation to perioperative changes in the modified lung ultrasound score.

  • Fresh Gas Flow Rate of 3 L/minOther

    During routine inhalational general anesthesia, a fresh gas flow rate of 3 L/min was used. The flow rate was selected independently by the attending anesthesiologist according to routine clinical practice and was not assigned or modified by the research protocol. This exposure was evaluated in relation to perioperative changes in the modified lung ultrasound score.

Study groups in NCT07758517
Study groupRoleWhat they receive
1 L/min Fresh Gas Flow CohortParticipants who received inhalational general anesthesia with a fresh gas flow rate of 1 L/min as part of routine anesthetic care. The fresh gas flow rate was selected independently by the attending anesthesiologist and was not assigned by the research protocol. Perioperative lung aeration was evaluated using the modified lung ultrasound score.
Receives: Other: Fresh Gas Flow Rate of 1 L/min
3 L/min Fresh Gas Flow CohortParticipants who received inhalational general anesthesia with a fresh gas flow rate of 3 L/min as part of routine anesthetic care. The fresh gas flow rate was selected independently by the attending anesthesiologist and was not assigned by the research protocol. Perioperative lung aeration was evaluated using the modified lung ultrasound score.
Receives: Other: Fresh Gas Flow Rate of 3 L/min

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Perioperative Change in Modified Lung Ultrasound Score

    Lung aeration was assessed in 12 thoracic regions, six regions in each hemithorax. Each region was scored from 0 to 3: 0 indicated normal aeration, 1 mild loss of aeration, 2 moderate loss of aeration, and 3 severe loss of aeration or consolidation. Regional scores were summed to obtain a total modified lung ultrasound score ranging from 0 to 36. Higher scores indicated greater loss of lung aeration. Changes in the total score across the perioperative time points were compared between the 1 L/min and 3 L/min fresh gas flow cohorts.

    Measured: Preoperative baseline; after tracheal intubation; before extubation; 15 minutes after PACU admission; and approximately 30 minutes after PACU admission or before PACU discharge

Secondary outcomes (6)
  1. Perioperative Peripheral Oxygen Saturation

    Peripheral oxygen saturation (SpO2), expressed as a percentage, was measured using pulse oximetry. Values recorded at the prespecified perioperative time points were compared between the 1 L/min and 3 L/min fresh gas flow cohorts.

    Measured: Preoperative baseline; after tracheal intubation; before extubation; 15 minutes after PACU admission; and approximately 30 minutes after PACU admission or before PACU discharge

  2. Intraoperative Dynamic Lung Compliance

    Dynamic lung compliance was obtained from the anesthesia machine and recorded in mL/cmH2O. Higher values indicated greater respiratory system compliance. Values were compared between the two fresh gas flow cohorts.

    Measured: Approximately 5 minutes after tracheal intubation and immediately before extubation

  3. Intraoperative Peak Airway Pressure

    Peak airway pressure was obtained from the anesthesia machine and recorded in cmH2O during mechanical ventilation. Values were compared between the 1 L/min and 3 L/min fresh gas flow cohorts.

    Measured: Approximately 5 minutes after tracheal intubation and immediately before extubation

  4. Intraoperative Airway Resistance

    Airway resistance was obtained from the anesthesia machine during mechanical ventilation and compared between the 1 L/min and 3 L/min fresh gas flow cohorts.

    Measured: Approximately 5 minutes after tracheal intubation and immediately before extubation

  5. Postoperative Pain Intensity

    Postoperative pain intensity was assessed using a visual analog scale ranging from 0 to 10, where 0 indicated no pain and 10 indicated the worst imaginable pain.

    Measured: At 15 minutes and approximately 30 minutes after admission to the PACU

  6. Incidence of Nausea, Vomiting, and Shivering in the PACU

    The occurrence of postoperative nausea, vomiting, and shivering was recorded as present or absent for each participant during recovery in the post-anesthesia care unit. Each event was evaluated separately as the number and percentage of participants experiencing the event.

    Measured: From admission to the PACU until PACU discharge, approximately 30 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Aug 2026
  2. Study start10 Jan 2024
  3. Primary completion10 Jan 2025
  4. Study completion15 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
2 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07758517
Sponsor's protocol ID
FSM-LUS-2023
Other IDs
2023/129
Status last verified
Aug 2026
First submitted
6 Aug 2026
Last updated
11 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Atelectasis and Nasal Septal Deviation, run by Fatih Sultan Mehmet Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Perioperative Change in Modified Lung Ultrasound Score (time frame: Preoperative baseline; after tracheal intubation; before extubation; 15 minutes after PACU admission; and approximately 30 minutes after PACU admission or before PACU discharge). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in